Search Results 271-280 of 16530 for ������������KA���:ZA31���24������ ���������������������������������
About this study. The purpose of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm ...
Cediranib maleate and olaparib may stop the growth of tumor cells by blocking enzymes needed for cell growth. Drugs used in chemotherapy work in different ways ...
Cabozantinib-s-malate and sunitinib malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known ...
Life expectancy < 24 months due to associated non-cardiac co-morbid conditions; Other medical, social, or psychological conditions that in the opinion of an ...
Lee YS, Khan AA. Financial Toxicity for Female Patients with Urinary Incontinence. Curr Urol Rep. 2023 Jan; 24(1):33-39. Epub 2022 Dec 17.
Jacksonville, Florida: 24-003633; Rochester, Minnesota: 24-003633. NCT ID: NCT05954312. Sponsor Protocol Number: VVD-130037-001. About this study. The purpose ...
... KA, Fuentes Bayne HE, Rwigema JCM, Patel SH ... 2025; 36(1):14-24. Epub 2024 Aug 09. Calcano GA ... 2021 Jul; 82 (Suppl 3):e138-e147 Epub 2020 Jan 24
2020 Feb 11; 117 (6):3053-3062 Epub 2020 Jan 24. View PubMed; Shomorony I ... KE, Brar P, Kahn AM, Spector TD, Caskey CT, Venter JC, Karow DS, Kirkness ...
Jacksonville, Florida: 24-007139. About this study. The purpose of this study is to use Canine Assisted Therapy (CAT) in patients undergoing office procedures ...
The study will assess proteinuria by 24-hour urine protein excretion (UPE) in g/day at 36 weeks from beginning of treatment. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.